UK deal over inclisiran

BMJ. 2020 Feb 18:368:m579. doi: 10.1136/bmj.m579.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Cardiovascular Diseases / prevention & control
  • Clinical Trials as Topic
  • Drug Industry
  • Humans
  • Hypercholesterolemia / drug therapy
  • PCSK9 Inhibitors
  • Public-Private Sector Partnerships*
  • RNA, Small Interfering / therapeutic use*
  • United Kingdom

Substances

  • ALN-PCS
  • Anticholesteremic Agents
  • PCSK9 Inhibitors
  • RNA, Small Interfering